CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,875 | -36.2% | 15,668 | 0.0% | 0.00% | – |
| Q2 2023 | $35,880 | +28.1% | 15,668 | +39.7% | 0.00% | – |
| Q4 2021 | $28,000 | -49.1% | 11,217 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | +27.9% | 11,217 | -18.9% | 0.00% | – |
| Q1 2021 | $43,000 | -70.5% | 13,830 | -61.9% | 0.00% | – |
| Q1 2019 | $146,000 | +52.1% | 36,275 | +40.1% | 0.00% | – |
| Q4 2018 | $96,000 | -57.0% | 25,900 | 0.0% | 0.00% | – |
| Q3 2018 | $223,000 | -21.8% | 25,900 | 0.0% | 0.00% | – |
| Q2 2018 | $285,000 | +41.1% | 25,900 | +48.0% | 0.00% | – |
| Q1 2018 | $202,000 | +11.0% | 17,500 | 0.0% | 0.00% | – |
| Q4 2017 | $182,000 | -34.8% | 17,500 | 0.0% | 0.00% | – |
| Q3 2017 | $279,000 | +31.6% | 17,500 | 0.0% | 0.00% | – |
| Q2 2017 | $212,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |